diaPatch™
diaPatch™ is a wearable diagnostic patch that uses microneedles to collect interstitial fluid from the low external abdominal pelvic region and a novel molecular assay to detect tumor-associated microRNA (miRNA) signals relevant to cervical cancer care.
diaPatch™ screens and detects -
Cervical cancer
(CIN II/CIN III), and ovarian cancer biomarkers
Initial intended use (alpha (α) product): cervical risk stratification/triage (adjunctive).
Future indications in gynecologic cancer and beyond: (Beta (β) product): additional biomarkers/indications for ovarian cancer, endometrial cancer, etc following clinical validation and regulatory clearance.
What Makes diaPatch™ Exciting?
-
First-in-class- FemTech wearable diagnostic patch designed for patient-centric, non-invasive sampling and same-visit workflow efficiencies.
-
Designed to improve annual wellness visits, telehealth and any other workflows, therefore creating efficiencies in oncology triage plus care.
-
Developed through interdisciplinary sprints and validated stepwise through feasibility and intended-use pilots.
Disclaimer: diaPatch™ is under development and is intended to be offered initially for research use only (RUO) as studies progress. Curiva plans to pursue FDA regulatory authorization prior to any commercial clinical diagnostic use.
.png)
.png){kind=small}
.png){kind=small}